FDA Inspection
Novo Nordisk A/S - 25a-BFDA Inspection 1207487 - Novo Nordisk A/S - 25a-B - November 04, 2022
Record Details
This FDA Inspection record concerns Novo Nordisk A/S - 25a-B, with an inspection on November 4, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Novo Nordisk A/S - 25a-B
- Inspection Date
- November 4, 2022
- Product Type
- Drugs
View Company Profile
ID · ea79a155-481b-4679-9086-1db6a43fbf49
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1207487
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Novo Nordisk A/S - 25a-B
7| Date | Classification | Office | Project area |
|---|---|---|---|
| November 7, 2023 | Not classified | Office of Inspections and Investigations | |
| June 14, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 22, 2016 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 18, 2015 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
| October 10, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Novo Nordisk A/S - 25a-B
- FDA Inspection 1223821 - 2023-11-07
- FDA Inspection 1118196 - 2018-06-14
- FDA Inspection 957571 - 2016-01-22
- FDA Inspection 933969 - 2015-06-18
- FDA Inspection 909374 - 2014-10-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.